Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics

被引:24
|
作者
Dunleavy, Katie A. [1 ]
Raffals, Laura E. [1 ]
Camilleri, Michael [1 ,2 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Clin Enter Neurosci Translat & Epidemiol Res CENT, Rochester, MN USA
关键词
Intestinal permeability; Inflammatory bowel disease; Mucus; Tight junctions;
D O I
10.1007/s10620-023-08122-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The intestinal barrier is composed of several essential elements including luminal enzymes, bile acids, water layer, epithelial layer, and enterocyte layer. It acts as a dynamic interface between the luminal contents of food, commensal and pathogenic bacteria, and the gastrointestinal tract. The role of barrier dysfunction is of significant research interest in the development and targeted treatment of chronic inflammatory gastrointestinal conditions, such as inflammatory bowel disease. This review aims to examine the role of intestinal barrier dysfunction in the development of inflammatory bowel disease, the pathophysiology of increased barrier permeability in inflammatory bowel disease, and to explore potential treatment targets and clinical applications.
引用
收藏
页码:4306 / 4320
页数:15
相关论文
共 50 条
  • [41] Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy
    Kong, Chen
    Yang, Meifeng
    Yue, Ningning
    Zhang, Yuan
    Tian, Chengmei
    Wei, Daoru
    Shi, Ruiyue
    Yao, Jun
    Wang, Lisheng
    Li, Defeng
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 5389 - 5413
  • [42] Innovative therapeutics for inflammatory bowel disease
    Jesus K Yamamoto-Furusho
    World Journal of Gastroenterology, 2007, (13) : 1893 - 1896
  • [43] Novel therapeutics in inflammatory bowel disease
    Bernstein, CN
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (07) : 1081 - 1096
  • [44] Innovative therapeutics for inflammatory bowel disease
    Yamamoto-Furusho, Jesus K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (13) : 1893 - 1896
  • [46] The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease
    Harris, Katharine G.
    Chang, Eugene B.
    CLINICAL SCIENCE, 2018, 132 (18) : 2013 - 2028
  • [47] Intestinal flora and chronic inflammatory bowel disease. Implications for pathogenesis and therapy
    Otte, J. -M.
    Schmidt, W. E.
    GASTROENTEROLOGE, 2007, 2 (06): : 430 - 439
  • [48] Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease
    Uhlig, Holm H.
    Powrie, Fiona
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (08) : 2021 - 2026
  • [49] Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease
    Takaishi, Hirornasa
    Matsuki, Takahiro
    Nakazawa, Atsushi
    Takada, Toshihiko
    Kado, Shoichi
    Asahara, Takashi
    Kamada, Nobuhiko
    Sakuraba, Atsushi
    Yajima, Tornoharu
    Higuchi, Hajime
    Nagamu, Inoue
    Ogata, Haruhiko
    Iwao, Yasushi
    Nomoto, Koji
    Tanaka, Ryuichiro
    Hibi, Toshifumi
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 298 (5-6) : 463 - 472
  • [50] Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease
    Eksteen, B
    Miles, AE
    Grant, AJ
    Adams, DH
    CLINICAL MEDICINE, 2004, 4 (02) : 173 - 180